Ba253BINEB in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02182635 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 74
Last updated 2014-07-11
Summary
The objective of this study is to investigate the long-term safety of Ba253BINEB. Secondarily the long-term efficacy of Ba253BINEB is also investigated.
Conditions
- Pulmonary Disease, Chronic Obstructive
Interventions
- DRUG
-
Ba253BINEB
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-08-31
- Primary Completion
- 1999-03-31
More Related Trials
-
Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses of BI 11054 CL Administered With the Respimat® in Healthy Male Volunteers
NCT02273401 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
NCT07201051 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD
NCT00035828 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis
NCT05238675 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Pharmacokinetics of BEA 2180 BR in Healthy Male Volunteers
NCT02254720 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Feasibility of Ectoin® Inhalation Solution in Inflammatory Obstruction and Ageing of the Lung
NCT01225965 ·Status: COMPLETED ·Phase: NA
-
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
NCT05321082 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Safety and Efficacy of BOTOX in Adults With Moderate COPD
NCT06003049 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation
NCT04656275 ·Status: TERMINATED ·Phase: PHASE1
-
Safety Study of CTX-100 Inhalation Solution (Formerly ETX-100)
NCT00993707 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
NCT05321069 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses of BI 1744 CL in Healthy Male and Female Volunteers
NCT02171780 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Tiotropium on Airway Diameter in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02172391 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary Disease
NCT01322594 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2 Study to Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
NCT02538536 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
NCT07119229 ·Status: RECRUITING ·Phase: NA
-
A Study of Safety & Blood Levels of IDL-2965 in Healthy Subjects and Patients With a Special Type of Pulmonary Fibrosis
NCT03949530 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis
NCT04631016 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven Hyperinflation
NCT02172521 ·Status: COMPLETED
-
Drug Use Survey of RESPIMAT in Patients With COPD
NCT01145053 ·Status: COMPLETED
-
A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment
NCT07036523 ·Status: RECRUITING ·Phase: PHASE2
-
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
NCT06872892 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPD
NCT06533553 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
NCT06959095 ·Status: RECRUITING ·Phase: PHASE3
-
Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation
NCT04456673 ·Status: COMPLETED ·Phase: PHASE3